![Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 | Journal of Hematology & Oncology | Full Text Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-022-01362-9/MediaObjects/13045_2022_1362_Fig1_HTML.png)
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 | Journal of Hematology & Oncology | Full Text
![Thiol redox proteomics: Characterization of thiol‐based post‐translational modifications - Li - 2023 - PROTEOMICS - Wiley Online Library Thiol redox proteomics: Characterization of thiol‐based post‐translational modifications - Li - 2023 - PROTEOMICS - Wiley Online Library](https://analyticalsciencejournals.onlinelibrary.wiley.com/cms/asset/9983c4ef-719b-4ed8-8fbc-236fb2ddaa46/pmic.v23.13-14.cover.jpg?trick=1695612579303)
Thiol redox proteomics: Characterization of thiol‐based post‐translational modifications - Li - 2023 - PROTEOMICS - Wiley Online Library
![Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds](https://www.mdpi.com/biomolecules/biomolecules-13-00093/article_deploy/html/images/biomolecules-13-00093-g001.png)
Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds
![Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds](https://www.mdpi.com/biomolecules/biomolecules-13-00093/article_deploy/html/images/biomolecules-13-00093-g002a.png)
Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds
![Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds](https://www.mdpi.com/biomolecules/biomolecules-13-00093/article_deploy/html/images/biomolecules-13-00093-g002b.png)
Biomolecules | Free Full-Text | PI3K–AKT-Targeting Breast Cancer Treatments: Natural Products and Synthetic Compounds
![Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 | Journal of Hematology & Oncology | Full Text Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021 | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-022-01362-9/MediaObjects/13045_2022_1362_Fig3_HTML.png)